Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Groen

Showing results (401-410 of 456) with videos related to

Pageof 46
Sort By:
The European Respiratory Journal|June 3, 2017
Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?Jules L Derks, Robert Jan van Suylen, Erik Thunnissen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2018
Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma <i>In Situ</i>-A Nested Case-Control StudyLindy L Visser, Lotte E Elshof, Michael Schaapveld, et al.
Mabs|March 12, 2015
Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myelomaMarije B Overdijk, Sandra Verploegen, Marijn Bögels, et al.
Tropical Medicine & International Health : TM & IH|May 10, 2002
Measles in suburban Khartoum: an epidemiological and clinical studyS A Ibrahim, O M Mustafa, M M Mukhtar, et al.
Cell Reports|February 24, 2021
TET2 is a component of the estrogen receptor complex and controls 5mC to 5hmC conversion at estrogen receptor cis-regulatory regionsRebecca Broome, Igor Chernukhin, Stacey Jamieson, et al.
Breast Cancer Research and Treatment|May 4, 2021
Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancerEmma J Groen, Marieke E M van der Noordaa, Michael Schaapveld, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 26, 2019
Liposomal dexamethasone inhibits tumor growth in an advanced human-mouse hybrid model of multiple myelomaAnil K Deshantri, Marcel H Fens, Ruud W J Ruiter, et al.
Vaccine|March 21, 2001
Prevention of measles in Sudan: a prospective study on vaccination, diagnosis and epidemiologyR L de Swart, H S El Mubarak, H W Vos, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 17, 2017
A Rational Strategy for Reducing On-Target Off-Tumor Effects of CD38-Chimeric Antigen Receptors by Affinity OptimizationEsther Drent, Maria Themeli, Renée Poels, et al.
Archives of Toxicology|January 1, 1997
Impaired cellular immune response in rats exposed perinatally to Baltic Sea herring oil or 2,3,7,8-TCDDP S Ross, R L de Swart, H van der Vliet, et al.
Pageof 46

Showing results (401-410 of 456) with videos related to

Sort By:
Pageof 46
The European Respiratory Journal|June 3, 2017
Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?Jules L Derks, Robert Jan van Suylen, Erik Thunnissen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2018
Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma <i>In Situ</i>-A Nested Case-Control StudyLindy L Visser, Lotte E Elshof, Michael Schaapveld, et al.
Mabs|March 12, 2015
Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myelomaMarije B Overdijk, Sandra Verploegen, Marijn Bögels, et al.
Tropical Medicine & International Health : TM & IH|May 10, 2002
Measles in suburban Khartoum: an epidemiological and clinical studyS A Ibrahim, O M Mustafa, M M Mukhtar, et al.
Cell Reports|February 24, 2021
TET2 is a component of the estrogen receptor complex and controls 5mC to 5hmC conversion at estrogen receptor cis-regulatory regionsRebecca Broome, Igor Chernukhin, Stacey Jamieson, et al.
Breast Cancer Research and Treatment|May 4, 2021
Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancerEmma J Groen, Marieke E M van der Noordaa, Michael Schaapveld, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 26, 2019
Liposomal dexamethasone inhibits tumor growth in an advanced human-mouse hybrid model of multiple myelomaAnil K Deshantri, Marcel H Fens, Ruud W J Ruiter, et al.
Vaccine|March 21, 2001
Prevention of measles in Sudan: a prospective study on vaccination, diagnosis and epidemiologyR L de Swart, H S El Mubarak, H W Vos, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 17, 2017
A Rational Strategy for Reducing On-Target Off-Tumor Effects of CD38-Chimeric Antigen Receptors by Affinity OptimizationEsther Drent, Maria Themeli, Renée Poels, et al.
Archives of Toxicology|January 1, 1997
Impaired cellular immune response in rats exposed perinatally to Baltic Sea herring oil or 2,3,7,8-TCDDP S Ross, R L de Swart, H van der Vliet, et al.
Pageof 46